Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
Financials
Financial year 2025
TRIPHARMA from Sint-Jans-Molenbeek, company number BE0426092096, closed financial year 2025 with a result of € 68,582 after tax. For that financial year TRIPHARMA recorded a gross margin of € 192,907 and equity of € -28,957. Compared with financial year 2024, the result moved from € 4,799 to € 68,582. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.
€ -28,957
▲ € 68,582 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 68,582
▲ € 63,783 vs 2024
Profit after tax over the fiscal year.
€ 44,513
▲ 134% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -47,549.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 85,700
▲ 18% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 1,408
▼ 86% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 102,442
▼ 37% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 11,946
▼ 18% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 112,387 | € 39,417 | € 103,611 | € 192,907 | ▲ 86% |
| Profit after taxes | € 8,875 | € -71,337 | € 4,799 | € 68,582 | ▲ € 63,783 |
| Equity | € -31,001 | € -102,338 | € -97,539 | € -28,957 | ▲ € 68,582 |
| Total debts | € 358,028 | € 435,855 | € 504,685 | € 295,300 | ▼ 41% |
| Cash | € 35,145 | € 25,380 | € 19,004 | € 44,513 | ▲ 134% |
| Land & buildings | € 164,500 | € 156,100 | € 147,700 | € 0 | ▼ 100% |
| Retained profit | € -49,593 | € -120,930 | € -116,131 | € -47,549 | ▲ € 68,582 |
| Bank debt | € 160,252 | € 141,394 | € 125,170 | € 0 | ▼ 100% |
| Balance sheet total | € 327,027 | € 333,516 | € 407,146 | € 266,344 | ▼ 35% |
Key figures of TRIPHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to TRIPHARMA?
What happened at TRIPHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 68,582 (▲ € 63,783 vs 2024). filed late Source: NBB ↗
- Sébastien MOREL became a director. NBB
- New establishment in Sint-Jans-Molenbeek. KBO
- Start of the company according to the CBE. KBO
In short
From € 8,875 profit in 2022 to € 68,582 profit in 2025.
Paid € 5,850 in corporate taxes since 2022.
Best year ever: 2025, with € 68,582 profit.
A new publication or filing at TRIPHARMA? We notify you, reason included.
Follow TRIPHARMADatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2025 annual accounts
Sébastien MOREL
Manager
since 2000
Establishments
Establishment units
Physical locations of this company
Jubelfeestlaan 119
1080 Sint-Jans-Molenbeek
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0426.092.096
- VAT number
- BE 0426.092.096
- Registered office
- Jubelfeestlaan 119, 1080 Sint-Jans-Molenbeek
- Names & denominations
- TRIPHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 6 June 1984
- Peppol
- Active · Active since 6 Feb 2026
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers